300254 仟源医药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.8977.6758.9474.288-20.358
总资产报酬率 ROA (%)0.2071.5582.8311.670-7.619
投入资产回报率 ROIC (%)0.2842.3614.0202.145-9.679

边际利润分析
销售毛利率 (%)66.97667.38266.90867.78869.735
营业利润率 (%)3.2839.1617.6775.024-13.883
息税前利润/营业总收入 (%)10.74112.89711.39110.612-5.669
净利润/营业总收入 (%)4.5846.4818.8306.096-11.812

收益指标分析
经营活动净收益/利润总额(%)25.00795.21067.396-7.07073.038
价值变动净收益/利润总额(%)6.421-16.4805.63537.7763.811
营业外收支净额/利润总额(%)57.38712.13519.40527.361-27.853

偿债能力分析
流动比率 (X)0.9850.9790.8770.9630.847
速动比率 (X)0.7240.7630.6450.6760.675
资产负债率 (%)67.63663.81861.35145.68153.945
带息债务/全部投入资本 (%)45.94252.25244.10835.98448.279
股东权益/带息债务 (%)75.68753.56576.461154.16893.972
股东权益/负债合计 (%)40.97829.06036.12291.67367.268
利息保障倍数 (X)3.5375.2216.1062.871-1.093

营运能力分析
应收账款周转天数 (天)101.40573.53954.49047.10649.507
存货周转天数 (天)221.142168.378162.948156.661151.840